Literature DB >> 13231736

Experience with pyrazinamide.

B P POTTER, S F CHANG.   

Abstract

Entities:  

Keywords:  NICOTINIC ACID/derivatives; PARA-AMINOSALICYLIC ACID/therapeutic use; STREPTOMYCIN/therapeutic use; TUBERCULOSIS, PULMONARY/therapy

Mesh：

Substances：

Year:  1955        PMID： 13231736     DOI： 10.1378/chest.27.1.44

Source DB:  PubMed          Journal:  Dis Chest        ISSN： 0096-0217


× No keyword cloud information.
  2 in total

1.  Hyperuricaemia due to pyrazinamide.

Authors:  J SCHNEEWEISS; G W POOLE
Journal:  Br Med J       Date:  1960-09-17

2.  Clinical and toxicodynamic evidence that high-dose pyrazinamide is not more hepatotoxic than the low doses currently used.

Authors:  Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-05-03       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.